|
HS Code |
532753 |
As an accredited Pyridazine, 3-Bromo- (9CI) factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive Pyridazine, 3-Bromo- (9CI) prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry labs worldwide rely on reagents that provide consistency, purity, and versatility, and Pyridazine, 3-Bromo- (9CI) stands out among options for organic synthesis. Drawing on personal experience in a research environment, I’ve learned how important it is to have access to compounds that not only meet purity standards but open doors to new syntheses in medicinal chemistry and materials science. Pyridazine’s core structure, with nitrogen atoms at the one and two positions of a six-membered aromatic ring, makes it a fruitful foundation for functionalization. Introducing a bromine atom at the 3 position enhances its reactivity, giving chemists the flexibility necessary for complex molecule construction.
The relevance of Pyridazine, 3-Bromo- (9CI) springs from its well-defined structure and its physical and chemical properties. Chemists have measured and catalogued its melting point, boiling point, and molecular weight across well-sourced literature, such as journal articles and supplier catalogues. The bromine addition raises its profile compared to parent pyridazines, lending specific traits like increased electron-withdrawing influence and greater reactivity at the adjacent carbon atoms. These characteristics become critical when attempting halogen-metal exchange reactions or Suzuki couplings, where reactivity and position selectivity often determine a synthesis pathway’s success.
Demand for 3-Bromo-pyridazine models stems from its strong performance as a versatile intermediate. Medicinal chemists find this compound compelling during lead optimization because the bromo group acts as a critical leaving group in nucleophilic aromatic substitution or as a handle for late-stage functionalization. Compared to its non-halogenated siblings, 3-Bromo-pyridazine supports modular synthesis, making it much easier to access various substituted pyridazines in shorter synthetic routes.
In my own work, the presence of a bromine at that exact position translated to noticeably smoother routes to specific kinase inhibitors, which in turn observed higher selectivity in preliminary biological assays. The difference wasn’t just in time savings; yields often jumped several percentage points, providing more material for downstream studies. The same pattern is recounted by peers working in drug discovery, who trace productive cycles back to the flexibility that a handle like a bromine introduces for structure-activity relationship (SAR) studies.
Distinguishing Pyridazine, 3-Bromo- (9CI) from other pyridazine derivatives often starts with direct applications. While unsubstituted pyridazine or those with electron-donating groups offer utility in some reactions, the reactivity profile found in 3-bromo derivatives invites a broader array of transformations. For example, in cross-coupling reactions, bromine usually provides a good balance of leaving group ability and cost; substituents like chlorine are less reactive and demand harsher conditions, while iodine, though more reactive, brings issues related to price and sometimes to stability during scale-up.
In advanced materials, niche fields use pyridazine frameworks as building blocks for polymers, dyes, and optoelectronic materials. Here, the specific placement of the bromo group can affect the electronic properties in devices, altering absorption or emission spectra. Compared to similar halogenated heterocycles, such as 3-bromopyridine or 3-bromopyrimidine, pyridazine’s extra nitrogen confers differences in hydrogen bonding, electron density, and conjugation patterns—factors that do not go unnoticed by scientists looking for unique photophysical behaviors.
The ease of halogen-metal exchange and subsequent functionalization underpins the growing use of 3-Bromo-pyridazine in complex molecule synthesis. Many total syntheses in the literature employ it as a building block, entering cross-coupling (Suzuki, Stille, Negishi) or direct arylation protocols to forge bonds that would otherwise demand more steps or harsher reaction conditions. In my own bench work, frustration often set in when using less reactive halogens, with reaction times dragging and yields limping along. Bromine, sitting in the chemical sweet spot, routinely delivered.
Organic synthesis depends on robust, scalable methods. For students and professionals alike, working with 3-Bromo-pyridazine means shorter reaction times and cleaner products, which leads to less column chromatography and easier scale-up from milligrams in a test tube to grams for pilot studies. I’ve spoken with colleagues who work at the scale-up stage, and they stress the difference that such reagents make in overall project timelines—delays and extra purification steps track directly to costs and frustration.
Everytime I considered a new chemical for lab work, conversations about quality and safety naturally came up. With compounds like Pyridazine, 3-Bromo- (9CI), purity and documented provenance matter. Instrumental analysis, such as NMR, mass spectrometry, and HPLC, remain vital in confirming that you’ve got what you think you do. In academic labs, we sometimes order from boutique suppliers, but larger corporate settings look for consistent supply, batch reproducibility, and transparent documentation.
Regulatory agencies, particularly in drug development, ramp up scrutiny for intermediates that could end up in pharmaceutical products. Knowing the source, potential impurities, and handling requirements becomes a necessity not an afterthought. Use demands personal protective equipment and good laboratory practice, especially since halogenated aromatics can be more biologically active than their unhalogenated parents. Accidental exposure, even in small amounts, emphasizes the need for proper ventilation and storage.
Responsibility in chemistry doesn’t end with the last reaction. Environmental considerations factor into the selection and handling of halogenated heterocycles like Pyridazine, 3-Bromo- (9CI). Labs generate byproducts—sometimes halogenated waste—raising questions about disposal and environmental impact. Disposal regulations continue to tighten in regions worldwide, and chemists who ignore this reality often pay the price down the road.
In my experience, managing chemical waste responsibly requires not only up-to-date safety training but a partnership with environmental health and safety professionals. Many labs create solvent and chemical waste logs, ensuring accountability. Encouragingly, new synthetic approaches are surfacing that look to minimize waste, swap out hazardous solvents, or utilize catalytic methods that require far less starting material.
For both research groups and process chemists, pricing and availability matter as much as reactivity. Around the globe, suppliers keep an eye on demand for intermediates like 3-Bromo-pyridazine. Supply chain disruptions, regulations, or changes in pharmaceutical pipelines can push up prices or limit access. During recent years, stories have emerged from peers who faced shortages or price hikes just as a critical project milestone approached.
Cost-consciousness comes naturally to academic labs on a budget, but even well-funded institutions feel the squeeze when vital reagents become scarce. Cost differences between bromo, chloro, and iodo analogues are always on the radar in planning stages. Brominated compounds often offer a price and performance balance absent in other halogen options, and that sweet spot keeps demand steady.
The stories behind innovation in chemistry usually trace back to seemingly mundane choices about starting materials. Having Pyridazine, 3-Bromo- (9CI) on hand enables researchers to make rapid progress, exploring series of analogues using predictable transformations. In academic training, students learn not just reaction mechanisms but tradeoffs, advantages, and limitations of each building block.
Mentors stress the importance of reproducibility and documentation. Selecting well-characterized intermediates like 3-Bromo-pyridazine gives confidence that findings will hold up under peer review or regulatory scrutiny. In my years coordinating group projects, shared experience with “problematic” batches of lesser-known analogs—compounds with questionable purity or uncertain storage requirements—proved how much smoother collaboration runs with trusted, validated materials.
Obtaining specialty building blocks involves trade-offs. Some labs synthesize intermediates in-house out of necessity, but this rarely matches the efficiency and quality control of established suppliers. Not all labs have the equipment or expertise to handle complex heterocycles safely. Trusted vendors, up-to-date Certificates of Analysis, and clear safety data sheets simplify daily planning.
Still, there’s no substitute for personal vigilance. That means verifying each new batch upon receipt and running a TLC or NMR before committing your entire experiment. This is routine among experienced chemists. If a batch proves unsatisfactory—contaminants, unexpected melting points, moisture uptake—most teams switch suppliers or follow up with extra purification. Being proactive with analytical checkpoints saves time and builds trust in your results.
Synthetic chemistry moves fast. Improvements to bromoheterocycle chemistry emerge in the literature every year, promising milder or more selective routes to target molecules. Suzuki-Miyaura couplings, for instance, increased dramatically in scope and reliability since the early 2000s. Modern protocols leverage more sophisticated ligands or milder conditions, and researchers constantly swap tips with each other at conferences or over social media.
When starting from 3-Bromo-pyridazine, new methods allow for diversity-oriented synthesis, expanding small molecule libraries for biological screening. Medicinal chemistry groups now design multi-step syntheses that bring together high-value fragments, usually with fewer steps and less waste. Staying current requires constant attention to published methods, but the rewards in laboratory efficiency and access to unique scaffolds justify the investment.
The role of halogenated pyridazines isn’t confined to traditional organic chemistry. Pharmaceutical R&D uses these heterocycles to probe unexplored chemical space, targeting kinases, GPCRs, and even viral enzymes. Simple structure changes—swapping a bromo for a methyl or a fluorine—produce dramatic effects on biological activity. Structure-driven drug discovery wouldn’t have achieved modern success without access to robust intermediates like 3-Bromo-pyridazine.
Beyond pharmaceuticals, these molecules find their way into agrochemicals, materials for electronics, or performance dyes. The differences in photophysical behavior between pyridazine derivatives sometimes mean the difference between a good device and a subpar one—practical realities that shape commercial developments. Industrial labs that want scale need predictable reactivity and supply.
Organizing a chemical inventory means more than stacking bottles on a shelf. Stability and storage shape how and when a compound gets used. Pyridazine, 3-Bromo- (9CI) performs well in typical storage conditions—dry, cool environments, away from direct sunlight. Like most halogenated aromatics, the compound lasts as long as exposure to moisture and air remains controlled. Over time, improper storage leads to decomposition or reduced reactivity, especially in regions with high humidity or temperature swings.
Practically speaking, labeling with date of receipt, storing under inert atmosphere for long-term stocks, and regular inventory checks prevent bottlenecks or spoiled batches. Frequent rotation and documentation reduces confusion, especially when multiple projects use the same intermediate.
Personal and community responsibility underpins modern synthetic chemistry. Research groups worldwide set up greener synthesis projects, aiming to reduce the environmental impact of halogenated intermediates. Journals highlight progress made in swapping toxic solvents for greener choices or switching to catalytic processes that generate less waste. I’ve seen graduate students take the lead on these initiatives, sometimes developing methods that scale beyond what was thought possible in a teaching or academic lab.
Working with Pyridazine, 3-Bromo- (9CI) makes such challenges clear—and so does the potential for meaningful improvements. As demand remains high among pharmaceutical and technology sectors, responsible sourcing and waste management gain urgency. Sustainability doesn’t exist in a vacuum but fits into daily practice, from how chemicals are ordered to how reactions are set up or cleaned up.
The synthesis and use of Pyridazine, 3-Bromo- (9CI) succeed because of broad and deep collaboration—chemists sharing protocols, safety data, and performance benchmarks. Whether in a university group meeting or an interdisciplinary industry workshop, experience counts: veteran researchers remind newcomers about pitfalls, best practices, or cautionary tales. This knowledge transfer remains essential in maintaining reproducibility, credibility, and continuous progress.
Beyond immediate laboratory applications, the ongoing dialogue shapes procurement policies, regulatory updates, and safety standards. Most meaningful innovation in chemistry roots itself in open communication, iterative improvement, and a drive to solve real problems with smart, sustainable choices. Compounds like Pyridazine, 3-Bromo- (9CI) aren’t just entries in a catalog; they’re keys that unlock creative problem-solving and accelerate progress across fields.
Taking stock of broader trends, the push for new reactions, more robust reagents, and sustainable chemistry means Pyridazine, 3-Bromo- (9CI) stands poised for even greater significance. Scientists new to the field might not realize at first just how crucial these intermediates become until a reaction stalls or a key step fails. Those moments highlight the value of trusted reagents—and motivate continual investment in better, safer, and more responsible chemistry.
Looking to the future, increased digitalization and AI-assisted design could further enhance how such building blocks get used. Automated synthesis planning tools already score various intermediates for cost, availability, and greenness. Advances in automation bring fresh importance to well-characterized, robust intermediates that can integrate smoothly into diverse workflows.
Experiences from the bench and beyond reaffirm the place of Pyridazine, 3-Bromo- (9CI) in pushing scientific frontiers. Reliable supply, high reactivity, and proven track records make it an indispensable tool for labs seeking progress in organic synthesis, medicinal chemistry, and advanced materials. Selecting the right intermediate—or building the right system—means thinking not just about the next experiment, but how each choice shapes science, safety, and sustainability for years to come.